The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb.
The commissioner was peppered with several questions about CBD and food supplements during the House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies hearing on the status of operations at FDA on February 27th.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets. Most content is available to subscribers only.
Use the code CBD15OFF to apply the discount on the following available reports:
Interest booming in online CBD sales: Germany market report
· CBD in the UK: consumer choices and behaviours under the spotlight
· EU states could deem CBD, other cannabinoids illegal in cosmetics
· Cannabis to be legalised? Mexico regulatory report